The American Journal of Managed Care6d
Ticagrelor Antidote Bentracimab Safely Reverses Antiplatelet Effects in Phase 3 REVERSE-IT Trial
Late-breaking data showed almost all patients achieved normal blood clotting and vessel repair after bentracimab infusion.
Managed Healthcare Executive3d
Monoclonal Antibody Bentracimab Shown to Reverse Antiplatelet Effect of Brilinta | ACC 2025
A BLA has been filed for bentracimab and, if approved, has the potential to be the first therapy to reverse the effects of ...
Bentracimab reverses ticagrelor's antiplatelet effects during surgery and bleeding events
A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor's antiplatelet effects in patients undergoing urgent surgery or experiencing major ...
Mirage News3d
Monoclonal Antibody Reverses Heart Attack Drug Effects
An investigational monoclonal antibody called bentracimab can safely and effectively reverse potentially catastrophic ...
MedPage Today on MSN3d
Runners' Cardiac Toll Down; IABP Flop in Cardiogenic Shock; Progress on Oral PCSK9i
The full results of the phase III REVERSE-IT trial continue to show that ticagrelor (Brilinta)-reversing therapy bentracimab ...
MedPage Today4d
Runners' Cardiac Toll Down; IABP Flop in Cardiogenic Shock; Progress on Oral PCSK9i
(Pittsburgh Post-Gazette) The full results of the phase III REVERSE-IT trial continue to show that ticagrelor (Brilinta)-reversing therapy bentracimab works to get people to a normalized platelet ...